Ginkgo Bioworks

DNA • NYSE • Stock Fundamentals

Ginkgo Bioworks is a biotechnology company in the healthcare sector trading on NYSE, led by CEO Jason Kelly, with a market cap of $522.6M.

Market Cap$522.6M

Employees1.2K

CEOJason Kelly

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsAfter Market Close · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Ginkgo Bioworks

Ginkgo Bioworks (DNA) has a market capitalization of $522.6M and trades on NYSE.

Ginkgo Bioworks has approximately 1,218 employees.